We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RGC market cap is 73.68M. The company's latest EPS is USD -0.3306 and P/E is -17.12.
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -812k | -1.38M | -7.62M | -6.27M | -4.74M |
Net Income | -812k | -1.35M | -7.6M | -5.87M | -4.3M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 514k | 340k | 18.02M | 12.62M | 8.44M |
Total Liabilities | 3.17M | 4.34M | 938k | 633k | 219k |
Total Equity | -2.65M | -4M | 17.08M | 11.99M | 8.22M |
Quarter End | |||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | |||||
Investing | |||||
Financing |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -726k | -767k | -5.27M | -4.96M | -4M |
Investing | -118k | N/A | -10.78M | 59k | 5.24M |
Financing | 988k | 440k | 22.41M | 135k | 102k |
Market Cap | 73.68M |
Price to Earnings Ratio | -17.12 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 24.88 |
Price to Book Ratio | 8.96 |
Dividend Yield | - |
Shares Outstanding | 13.01M |
Average Volume (1 week) | 62.52k |
Average Volume (1 Month) | 76.78k |
52 Week Change | -48.39% |
52 Week High | 32.44 |
52 Week Low | 3.00 |
Spread (Intraday) | 0.14 (2.48%) |
Company Name | Regencell Bioscience Holdings Ltd |
Address |
11/f first commercial building hong kong 999077 |
Website | https://www.regencellbioscience.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions